Inherited neurodegeneration is seen in a wide variety of human diseases. To gain an understanding of the molecular bases of how mutations can lead to nerve cell death, we have been studying such mutations in the nematode Caenorhabditis elegans, an organism in which advanced genetic and molecular analyses are possible. In the past we have identified a family of genes whose products, the degenerins, can be mutated to cause nerve cell death. In this proposal we wish to study several new genes that also can be mutated to cause similar deaths. The number of these new genes and their genetic properties suggest that most are not in the degenerin family and should provide new insights into the type of genes that can lead to inherited neurodegeneration. In addition, several of the mutations lead to sensory abnormalities, and we have hypothesized that they may cause degeneration by altering components needed for sensory transduction. The experiments in this proposal will test this hypothesis, with the added benefit that they may allow us to identify such components.
Our specific aims are: 1. to characterize molecular these new genes by cloning genomic DNA and cDNAs for at least three of them, analyzing the nature of the degeneration-causing mutations (by sequencing mutant DNAs), and localizing the products by lacZ fusions expression. 2. to continue the genetic characterization of these genes by doing saturation mutageneses to identify other genes of this type, by analyzing the null phenotype of the existing genes, and by obtaining and characterizing extragenic suppressor of one of the mutations, deg(u662) (we have identified one such gene already). The health relatedness of this project stems from the nature of the degeneration-causing mutations. Until the genes are cloned, we will not know whether there are human homologues (much less whether they are bases of any human diseases). Nonetheless, the study of these genes should highlight cell biological processes underlying inherited neurodegenerative disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-09
Application #
6234220
Study Section
Project Start
1997-06-15
Project End
1998-05-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425

Showing the most recent 10 out of 640 publications